Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study

BACKGROUND: In January, 2021, a vaccination campaign against COVID-19 was initiated with the rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines in Argentina. The objective of this study was to estimate vaccine effectiveness at reducing risk of SARS-CoV-2 infection and COVID-19 deaths in people old...

Descripción completa

Detalles Bibliográficos
Autores principales: Rearte, Analía, Castelli, Juan Manuel, Rearte, Ramiro, Fuentes, Nora, Pennini, Velen, Pesce, Martina, Barbeira, Pilar Barcena, Iummato, Luciana Eva, Laurora, Melisa, Bartolomeu, María Lucía, Galligani, Guido, Del Valle Juarez, María, Giovacchini, Carlos María, Santoro, Adrián, Esperatti, Mariano, Tarragona, Sonia, Vizzotti, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923678/
https://www.ncbi.nlm.nih.gov/pubmed/35303473
http://dx.doi.org/10.1016/S0140-6736(22)00011-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923678/
https://www.ncbi.nlm.nih.gov/pubmed/35303473
http://dx.doi.org/10.1016/S0140-6736(22)00011-3

Ejemplares similares